Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content. If you have any issues relating to the topics here, please call the MS-UK Helpline on 0800 7830 518.


 

New findings from a study by Merck KGaA, Darmstaft, Germany, a science and technology company operating as EMD Serono in Canada has shown that Cladribine Tablets can reduce brain atrophy, the rate...

Digesting Science has been awarded for its efforts in teaching young children about multiple sclerosis. The Queen Mary University of London (QMUL) Engagement and  Enterprise Awards 2017 recognise...

A drug, which has already been approved by the Food and Drug Federation has been found to supress chronic inflammation in the central nervous system in a mouse study. 

A research team led...

A major new study has revealed people who inherit genetic variants affecting the function of their immune system are at increased risk of developing the most common form of leukaemia.

...

Researchers in Australia have identified the first blood biomarker – a chemical identifier in the blood – for multiple sclerosis (MS). 

The findings are the result of a 12 year study that...

Results of a new clinical trial have provided evidence that high-dose immunosuppressive therapy followed by transplantation of a person’s own blood-forming stem cells can induce sustained...

The Scottish Government is working with The University of the West of Scotland (UWS) to fund two PhDs in multiple sclerosis (MS), with the university funding a further two places for the...

Statistically more women than men develop multiple sclerosis (MS), but new research may have discovered why.

Researchers of the study ‘Genetic Mechanisms Leading to Sex Differences Across...

Drug company Biogen has updated the possible side effects of MS drug Tecfidera, warning it may cause ‘significant liver injury’, which could require hospitalisation.

Liver injury has been...

Pages

Live Chat Software by Click4Assistance UK